The impact of antitumor therapy on cardiac systolic function in patients with non-hodgkin lymphoma

Back

HFA Premium Access

The impact of antitumor therapy on cardiac systolic function in patients with non-hodgkin lymphoma

Session: Chronic heart failure - pathophysiology and mechanisms 3

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Doctor D. Bursacovschi (Chisinau, MD)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor Daniela Bursacovschi

Institute of Cardiology, Chisinau (Moldova (Republic of))

0 follower

7 more presentations in this session

Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life

Speaker: Doctor R. Rascon Sabido (Veracruz, MX)

Correlation of sST2 with chosen biochemical parameters and influence on prognosis in patients hospitalized due to HFrEF.

Speaker: Doctor M. Dudek (Poznan, PL)

Long-term hydroxychloroquine exposure impairs the left ventricular longitudinal strain

Speaker: Doctor R. Didier (Dijon, FR)

Exrecise capacity dynamics in non-hodgkin lymphoma patients

Speaker: Doctor D. Bursacovschi (Chisinau, MD)

Implications of pulmonary artery pressures during both heart failure and non heart failure hospitalizations for subsequent hospitalization events

Speaker: Doctor M. Costanzo (Naperville, US)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 3

Speakers: Doctor D. Bursacovschi, Doctor R. Rascon Sabido, Doctor M. Dudek, Doctor R. Didier, Doctor D. Bursacovschi...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources